期刊文献+

结核分枝杆菌H37Rv新基因Rv2742克隆表达及纯化 被引量:6

Cloning, expression and purification of novel gene Rv2742 in Mycobacterium tuberculosis H37Rv
原文传递
导出
摘要 Rv2742是本课题组前期基于蛋白质基因组学策略从结核分枝杆菌Mycobacteriumtuberculosis H37Rv中发现、鉴定的遗漏注释基因。文中旨在建立结核分枝杆菌H37Rv漏注释蛋白Rv2742的可溶性诱导表达、纯化体系,为进一步探索Rv2742基因参与的生物学功能奠定基础。前期实验发现构建的pGEX-4T-2-Rv2742、pET-28a-Rv2742、pET-32a-Rv2742及pMAL-c2X-Rv2742原核表达载体均无法实现目的蛋白的诱导表达。但经密码子优化后,仅有pMAL-c2X-Rv2742载体能够实现目的蛋白的可溶性诱导表达。此外,通过比较不同宿主菌、温度及IPTG浓度对目的蛋白表达量的影响,发现目的蛋白在Rosetta (DE3)中,16℃及0.5mmol/LIPTG诱导条件下表达量最高。直链淀粉树脂(Amyloseresin)亲和层析柱纯化获得较纯的产物,经LC-MS/MS验证确认是Rv2742融合蛋白肽段序列。成功获得结核分枝杆菌H37Rv新基因Rv2742的重组蛋白,可进一步开展其潜在相互作用及免疫原性研究工作。 Rv2742 is a novel gene identified from Mycobacterium tuberculosis H37 Rv by the proteogenomics strategy.The aim of this study was to establish a system of soluble expression and purification of the missing protein Rv2742 in M.tuberculosis H37 Rv,to provide reference for further research on the biological function of Rv2742.The soluble protein was not successfully induced by prokaryotic expression vectors pGEX-4 T-2-Rv2742,pET-32 a-Rv2742,pET-28 a-Rv2742 and pMAL-c2 X-Rv2742.After the codon of novel gene Rv2742 was optimized according to E.coli codon usage frequency,only the recombinant strain containing plasmid pMAL-c2 X-Rv2742 could produce soluble products of Rv2742 encoding gene.In addition,the expression effects of the desired fusion protein were also analyzed under different conditions including hosts,culture temperatures and IPTG concentrations.The optimum expression conditions were as follows:Rosetta(DE3)host,16°C culture temperature and 0.5 mmol/L IPTG.After being purified by affinity chromatography with amylose resin,the fusion protein sequence was confirmed by LC-MS/MS.These results indicated that the novel gene Rv2742 product could be successfully induced and expressed in a soluble form by the expression system pMAL-c2X with MBP tag.Our findings provide reference for studies on potential interaction and immunogenicity.
作者 赵加玲 武舒佳 王红 李芊璘 孙金帅 常蕾 戴二黑 武军驻 张瑶 徐平 Jialing Zhao;Shujia Wu;Hong Wang;Qianlin Li;Jinshuai Sun;Lei Chang;Erhei Dai;Junzhu Wu;Yao Zhang;Ping Xu(School of Pharmaceutical Sciences,Wuhan University,Wuhan 430000,Hubei,China;School of Basic Medical Sciences,Wuhan University,Wuhan 430000,Hubei,China;State Key Laboratory of Proteomics,Beijing Proteome Research Center,National Center for Protein Sciences(Beijing),Beijing Institute of Lifeomics,Beijing 102206,China;School of Public Health and Affiliated Shijiazhuang Fifth Hospital,North China University of Science and Technology,Tangshan 063210,Hebei,China;School of Life Sciences,Hebei University,Baoding 071000,Hebei,China;School of Life Sciences,Sun Yat-sen University,Guangzhou 510275,Guangdong,China)
出处 《生物工程学报》 CAS CSCD 北大核心 2019年第9期1771-1786,共16页 Chinese Journal of Biotechnology
基金 国家精准医学重大专项(No.2017YFC0906600) 国家传染病重大专项(No.2018ZX10302302001003) 国家自然科学基金(Nos.31670834,31870824,91839302) 广东省基础及应用基础研究博士科研启动项目(No.2018A030310257)资助~~
关键词 结核分枝杆菌 新基因 原核表达 亲和纯化 Mycobacterium tuberculosis novel gene prokaryotic expression affinity purification
  • 相关文献

参考文献2

二级参考文献8

共引文献5

同被引文献27

引证文献6

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部